<PAGE>
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K/A
Amendment No. 1
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: SEPTEMBER 30, 1997
(Date of earliest event reported)
COMMISSION FILE NUMBER 0-14713
Interleaf
Interleaf, Inc.
(exact name of registrant as specified in its charter)
Massachusetts 04-2729042
(State or other jurisdiction (I.R.S. employer identification number)
of incorporation or organization)
62 Fourth Avenue, Waltham, MA 02154
(Address of principal executive offices) (Zip Code)
(617) 290-0710
(Registrant's telephone number, including area code)
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
<PAGE>
Interleaf, Inc.
Explanatory Note
This Form 8-K/A is being filed to revise Item 5 "Other Events" and Exhibit No.
99, as previously provided on Interleaf, Inc.'s Form 8-K filed September 30,
1997.
Item 5. Other Events
1997 Private Placement
On September 30, 1997, Interleaf, Inc. (the "Company") completed a private
placement transaction pursuant to which it received aggregate net proceeds
of approximately $6.8 million (after cash fees to the placement agent and
estimated transaction expenses) from the issuance of shares of the
Company's 6% Convertible Preferred Stock ("Convertible Preferred Stock")
and related placement agent warrants. Such transaction is referred to in
this Form 8-K/A as the "1997 Private Placement," and the related securities
issuances (including shares of the Company's Common Stock ("Common Stock")
issuable upon the conversion of shares of Convertible Preferred Stock, as
dividends thereon and upon exercise of the placement agent warrants) are
referred to as the "1997 Private Placement Issuances." All of the
securities sold in the 1997 Private Placement were sold in a private
placement solely to accredited investors. The offering is complete and all
shares of Convertible Preferred Stock have been placed, subject to
necessary shareholder approval as more fully described below.
Certain provisions relating to the conversion of the Convertible Preferred
Stock allow for their conversion at prices discounted to the trading price
from time to time of the Common Stock on the Nasdaq Stock Market, Inc.
("Nasdaq") national market. Upon such conversion, these provisions will
result in dilution to holders of outstanding shares of Common Stock.
However, under the terms of the Convertible Preferred Stock, no conversion
of the Convertible Preferred Stock into Common Stock is permitted for a
period of 90 days from and after the closing of the 1997 Private Placement
on September 30, 1997, so that no such dilution can take place for at least
this period.
Subsequent Filings
In accordance with Exchange Act Release No. 37801 (October 10, 1996), the
Company will make the disclosures required under Item 701 of Regulation S-K
in its quarterly report on Form 10-Q to be filed on or before November 14,
1997.
Communications With Nasdaq
By letter dated July 29, 1997, the Company was notified by Nasdaq that it
no longer met the requirement for continued listing on the Nasdaq
National Market. In letters dated September 5, 1997 and September 25,
1997, and as previously disclosed, Nasdaq informed the Company that in
order to prevent delisting the Company would need to complete the 1997
Private Placement and file this Form 8-K demonstrating compliance with
Nasdaq Marketplace Rule 4450(a)(3)(C) using pro-forma balance sheet with
June 30, 1997 as the base.
As a result of the 1997 Private Placement, the Company is able to
demonstrate such pro-forma compliance as shown in the pro-forma balance
sheet included under Item 7 of this Form 8-K. Such pro-forma balance sheet
has been prepared on the same basis of accounting as the Company's June 30,
1997 unaudited balance sheet and assumes that necessary shareholder
approval has been received. As such, the Company complies with Nasdaq
National Market listing requirements on October 1, 1997, subject to
shareholder approval of the 1997 Private Placement issuance.
<PAGE>
The Company has made the following commitments to Nasdaq in connection with
such continued listing:
- The Company will seek stockholder approval of the 1997 Private
Placement in a special meeting to be held not more than 90 days
after the closing of the transaction.
- The Company will reserve $1 million dollars from the proceeds of the
1997 Private Placement for a period of 18 months after the closing to
be used solely for purposes of funding the "Green Floor" which permits
the Company to make cash payments in lieu of certain 1997 Private
Placement Issuances. The Company will use the full $1 million to
exercise the "Green Floor" in order to prevent to the extent possible
dilution equaling or exceeding 20% of the total shares of Common Stock
outstanding prior to completion of the 1997 Private Placement.
- Common Stock issued upon the conversion of the Convertible Preferred
Stock will not be allowed to vote in the shareholder vote on the 1997
Private Placement.
Stockholder Approval
The Company intends to seek stockholder approval of the 1997 Private
Placement at a special meeting called solely for this purpose to be held at
the Company's principal executive offices at 62 Fourth Avenue, Waltham,
Massachusetts on or about December 17, 1997. The record date for this
special meeting has been set at November 17, 1997.
If the transaction is not approved by the stockholders, the 1997 Private
Placement will be unwound in part by redeeming, at a redemption price equal
to 110% of the liquidation preference of the Convertible Preferred Stock,
the smallest number of shares which is sufficient in the Company's
reasonable judgement, such that following such redemption, conversion of
the remaining shares of Convertible Preferred Stock will not constitute a
breach of the Company's obligations under the applicable Nasdaq rules.
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Exhibit
----------- --------
99 Pro Forma Balance Sheet of the Company, at June 30, 1997,
including the 1997 Private Placement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report on Form 8-K/A to be signed on its behalf by the
undersigned hereunto duly authorized.
INTERLEAF, INC.
October 23, 1997
/s/ Jaime W. Ellertson
----------------------
Jaime W. Ellertson
President
<PAGE>
Interleaf, Inc. Exhibit 99
Consolidated Balance Sheets
(In thousands)
<TABLE>
<CAPTION>
PROFORMA
JUNE 30, 1997 ADJUSTMENTS JUNE 30, 1997
------------- ----------- -------------
(UNAUDITED) (UNAUDITED)
<S> <C> <C> <C>
ASSETS
Current Assets
Cash and cash equivalents......................................... $ 18,031 $ 6,962 $ 24,993
Accounts receivable, net of reserve for doubtful accounts......... 7,922 7,922
of $1,377 at June 30, 1997....................................... 0
Prepaid expenses and other current assets......................... 1,532 1,532
------------- ----------- -------------
Total Current Assets.............................................. 27,485 6,962 34,447
Property and equipment, net....................................... 4,423 4,423
Intangible assets................................................. 1,946 1,946
Other assets...................................................... 444 444
------------- ----------- -------------
Total Assets...................................................... 34,298 6,962 41,260
------------- ----------- -------------
------------- ----------- -------------
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable.................................................. 2,544 50 2,594
Accrued expenses.................................................. 11,845 11,845
Unearned revenue.................................................. 13,819 13,819
Accrued restructuring............................................. 3,598 3,598
------------- ----------- -------------
Total Current Liabilities......................................... 31,806 50 31,856
Long-term restructuring........................................... 2,744 2,744
------------- ----------- -------------
Total Liabilities................................................. 34,550 50 34,600
------------- ----------- -------------
------------- ----------- -------------
Shareholders' Equity (Deficit)
Preferred stock, par value $.10 per authorized 5,000,000 shares:
Series A Junior Participating, none issued and outstanding
Senior Series B convertible, issued and outstanding, 861,911 at
June 30, 1997................................................... 86 86
Senior Series C convertible, issued and outstanding, 1,006,480 at
June 30, 1997................................................... 101 -- 101
Series D Convertible, issued and outstanding, 7,625 (proforma) -- 1 1
Common stock, par value $.01 per share, authorized 30,000,000
shares, issued and outstanding, 17,709,719 at June 30, 1997..... 177 177
Additional paid-in capital........................................ 85,747 6,911 92,658
Retained earnings(deficit)........................................ (86,122) (86,122)
Cumulative translation adjustment................................. (241) (241)
0
------------- ----------- -------------
Total Shareholders' Equity (Deficit).............................. (252) 6,912 6,660
------------- ----------- -------------
Total Liabilities and Shareholders' Equity (Deficit).............. $ 34,298 $ 6,962 $ 41,260
------------- ----------- -------------
------------- ----------- -------------
</TABLE>
